热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Brilliant Violet 421™ anti-mouse CD11c Antib
产品名称：
Brilliant Violet 421™ anti-mouse CD11c Antib
产品类别：
抗体
产品编号：
117329
产品应用：
117329
[价格]
规格 价格 库存
125µL ￥ 2112 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
?L sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the ?g size, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. For immunofluorescent staining using ?l sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor? 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  24. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Liu J, et al. 2019. Immunity. 50:600. PubMed
  2. R?dahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  3. Ortiz G, et al. 2020. Front Immunol. 11:1713. PubMed
  4. Kim EH, et al. 2020. Elife. 9:00. PubMed
  5. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  6. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  7. Szulc-D&acedil;browska L, et al. 2017. PLoS One. 12(6):e0179166. PubMed
  8. Park S, et al. 2021. Front Immunol. 11:620166. PubMed
  9. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  10. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  11. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  12. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  13. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  14. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  15. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  16. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  17. Saito S, et al. 2020. Nutrients. 12:. PubMed
  18. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  19. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  20. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  21. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  22. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  23. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  24. Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
  25. Gao H, et al. 2021. Cells. 10:. PubMed
  26. James BR, et al. 2014. Cancer Immunol Immunother. 63:1213-1227. PubMed
  27. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  28. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  29. Zheng J, et al. 2020. bioRxiv. . PubMed
  30. Hossain DMS, et al. 2018. J Clin Invest. 128:644. PubMed
  31. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  32. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  33. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  34. Jürchott K, et al. 2016. PLoS One. 11: 0150812. PubMed
  35. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  36. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  37. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  38. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  39. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  40. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  41. Zhang J, et al. 2018. Sci Rep. 8:2373. PubMed
  42. Matundan H, et al. 2019. J Virol. 93. PubMed
  43. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  44. Jaggi U, et al. 2021. PLoS Pathog. 17:e1009999. PubMed
  45. Zheng J, et al. 2020. Nature. . PubMed
  46. K?lin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  47. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  48. Giampazolias E, et al. 2021. Cell. . PubMed
  49. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  50. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  51. Wang S, et al. 2022. J Inflamm Res. 14:7107. PubMed
  52. Huang L, et al. 2021. Frontiers in Cellular and Infection Microbiology. 10:606340. PubMed
  53. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  54. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  55. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  56. Serr I, et al. 2016. Proc Natl Acad Sci U S A. 113: E6659 - E6668. PubMed
  57. Wang Y, et al. 2020. Vaccines (Basel). 8:. PubMed
  58. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  59. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  60. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  61. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  62. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  63. Lytle NK et al. 2019. Cell. 177(3):572-586 . PubMed
  64. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  65. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  66. Song W, et al. 2022. Immunity. 55:290. PubMed
  67. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  68. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
RRID
AB_10897814 (BioLegend Cat. No. 117329) AB_2563099 (BioLegend Cat. No. 117343) AB_11219593 (BioLegend Cat. No. 117330)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线